All Stories

  1. A Case Cluster of Aseptic Meningitis Associated With a Newly Identified Recombinant Echovirus 6/Coxsackievirus B1 Enterovirus

    Article • The Journal of Infectious Diseases, May 2025, Oxford University Press (OUP)

    Kartik Cherabuddi

  2. Impact of Timing of Beta-Lactam Therapeutic Drug Monitoring and Therapy Adjustment in Critically Ill Patients

    Article • Antibiotics, May 2025, MDPI AG

    Kartik Cherabuddi

  3. A case-cluster of aseptic meningitis associated with a newly identified recombinant echovirus6/CoxsackievirusB1 enterovirus

    Article • December 2024, Cold Spring Harbor Laboratory Press

    Kartik Cherabuddi

  4. Re-evaluation of cefepime or piperacillin/tazobactam to decrease use of carbapenems in ESBL-producing Enterobacterales urinary tract infections (REDUCE-UTI)

    Article • JAC-Antimicrobial Resistance, March 2023, Oxford University Press (OUP)

    Kartik Cherabuddi

  5. Digital cough monitoring – A potential predictive acoustic biomarker of clinical outcomes in hospitalized COVID-19 patients

    Article • Journal of Biomedical Informatics, February 2023, Elsevier

    Kartik Cherabuddi

  6. Use of therapeutic drug monitoring to characterize cefepime‐related neurotoxicity

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, December 2022, Wiley

    Kartik Cherabuddi

  7. Implementation of a β-lactam therapeutic drug monitoring program: Experience from a large academic medical center

    Article • American Journal of Health-System Pharmacy, June 2022, Oxford University Press (OUP)

    Kartik Cherabuddi

  8. Cefepime Precision Dosing Tool: from Standard to Precise Dose Using Nonparametric Population Pharmacokinetics

    Article • Antimicrobial Agents and Chemotherapy, February 2022, ASM Journals

    Kartik Cherabuddi

  9. 1101. Implementing a Beta-Lactam Therapeutic Drug Monitoring Program: Experience from a Large Academic Medical Center

    Article • Open Forum Infectious Diseases, November 2021, Oxford University Press (OUP)

    Kartik Cherabuddi

  10. 1257. Re-Evaluation of Cefepime or Piperacillin-Tazobactam to Decrease Use of Carbapenems in ESBL-Producing Enterobacterales Urinary Tract Infections (REDUCE-UTI)

    Article • Open Forum Infectious Diseases, November 2021, Oxford University Press (OUP)

    Kartik Cherabuddi

  11. Effect of losartan on hospitalized patients with COVID-19-induced lung injury: A randomized clinical trial

    Article • August 2021, Cold Spring Harbor Laboratory Press

    Kartik Cherabuddi

  12. Relationship of Multiplex Molecular Pneumonia Panel Results With Hospital Outcomes and Clinical Variables

    Article • Open Forum Infectious Diseases, July 2021, Oxford University Press (OUP)

    Kartik Cherabuddi

  13. India's COVID-19 crisis: a call for international action

    Article • The Lancet, June 2021, Elsevier

    Kartik Cherabuddi

  14. Resource Over-Utilization in Hospitalized Patients With Uncomplicated Skin and Soft Tissue Infections

    Article • Journal of Pharmacy Practice, March 2021, SAGE Publications

    Kartik Cherabuddi

  15. Vaccine Enthusiasm and Hesitancy in Cancer Patients and the Impact of a Webinar

    Article • Healthcare, March 2021, MDPI AG

    Kartik Cherabuddi

  16. Draft Genome Sequence of a Burkholderia cepacia Complex Strain Isolated from a Human Intra-abdominal Abscess

    Article • Microbiology Resource Announcements, March 2021, ASM Journals

    Kartik Cherabuddi

  17. Investing in the Future: A Role for Professional Societies to Prepare the Next Generation of Healthcare Leaders Through Curriculum Development and Dissemination

    Article • Clinical Infectious Diseases, March 2021, Oxford University Press (OUP)

    Kartik Cherabuddi

  18. In-Frame 12-Nucleotide Deletion within Open Reading Frame 3a in a SARS-CoV-2 Strain Isolated from a Patient Hospitalized with COVID-19

    Article • Microbiology Resource Announcements, February 2021, ASM Journals

    Kartik Cherabuddi

  19. Dissemination mechanisms of NDM genes in hospitalized patients

    Article • JAC-Antimicrobial Resistance, January 2021, Oxford University Press (OUP)

    Kartik Cherabuddi

  20. Optimizing COVID-19 testing capabilities and clinical management using pathology informatics

    Article • JAMIA Open, December 2020, Oxford University Press (OUP)

    Kartik Cherabuddi

  21. Performance of a Semiquantitative Multiplex Bacterial and Viral PCR Panel Compared With Standard Microbiological Laboratory Results: 396 Patients Studied With the BioFire Pneumonia Panel

    Article • Open Forum Infectious Diseases, November 2020, Oxford University Press (OUP)

    Kartik Cherabuddi

  22. Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients

    Article • International Journal of Infectious Diseases, November 2020, Elsevier

    Kartik Cherabuddi

  23. 1111. #BeASteward: Transforming Infectious Diseases Fellows Into Antimicrobial Stewards Using the IDSA Antimicrobial Stewardship Curriculum

    Article • Open Forum Infectious Diseases, October 2020, Oxford University Press (OUP)

    Kartik Cherabuddi

  24. Early therapeutic monitoring of β-lactams and associated therapy outcomes in critically ill patients

    Article • Journal of Antimicrobial Chemotherapy, September 2020, Oxford University Press (OUP)

    Kartik Cherabuddi

  25. Population Pharmacokinetics and Target Attainment of Cefepime in Critically Ill Patients and Guidance for Initial Dosing

    Article • Antimicrobial Agents and Chemotherapy, August 2020, ASM Journals

    Kartik Cherabuddi

  26. Use of Therapeutic Drug Monitoring to Characterize Cefepime-Induced Neurotoxicity

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Kartik Cherabuddi

  27. Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Kartik Cherabuddi

  28. Severe COVID-19 After Recent Heart Transplantation Complicated by Allograft Dysfunction

    Article • JACC Case Reports, July 2020, Elsevier

    Kartik Cherabuddi

  29. Chloroquine and hydroxychloroquine in the context of COVID-19

    Article • Drugs in Context, April 2020, BioExcel

    Kartik Cherabuddi

  30. Clostridioides difficile associated peritonitis in peritoneal dialysis patients – a case series based review of an under-recognized entity with therapeutic challenges

    Article • BMC Nephrology, March 2020, Springer Science + Business Media

    Kartik Cherabuddi

  31. Dissemination Mechanisms of New Delhi Metallo-β-lactamase Genes in Hospitalized Patients

    Article • SSRN Electronic Journal, January 2020, Elsevier

    Kartik Cherabuddi

  32. Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections

    Article • Antimicrobial Agents and Chemotherapy, November 2019, ASM Journals

    Kartik Cherabuddi

  33. Prophylactic antibiotics in head and neck free flap surgery: A novel protocol put to the test

    Article • American Journal of Otolaryngology, November 2019, Elsevier

    Kartik Cherabuddi

  34. Application of an objective structured clinical examination to evaluate and monitor interns’ proficiency in hand hygiene and personal protective equipment use in the United States

    Article • Journal of Educational Evaluation for Health Professions, October 2019, Korea Health Personnel Licensing Examination Institute

    Kartik Cherabuddi

  35. 1181. Use of the Combination Antibiogram in the Era of MDR Gram-Negative Pathogens

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Kartik Cherabuddi

  36. 2425. Clinical and Microbiologic Outcomes Among Patients With Monomicrobial Stenotrophomonas maltophilia Infections

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Kartik Cherabuddi

  37. Assessing antimicrobial stewardship initiatives: Clinical evaluation of cefepime or piperacillin/tazobactam in patients with bloodstream infections secondary to AmpC-producing organisms

    Article • International Journal of Antimicrobial Agents, November 2018, Elsevier

    Kartik Cherabuddi

  38. SCAN: A novel approach for vancomycin time-out

    Article • Infection Control, October 2018, Cambridge University Press

    Kartik Cherabuddi

  39. Keystone Virus Isolated From a Florida Teenager With Rash and Subjective Fever: Another Endemic Arbovirus in the Southeastern United States?

    Article • Clinical Infectious Diseases, June 2018, Oxford University Press (OUP)

    Kartik Cherabuddi

  40. Antimicrobial Stewardship Training for Infectious Diseases Fellows: Program Directors Identify a Curriculum Need

    Article • Clinical Infectious Diseases, April 2018, Oxford University Press (OUP)

    Kartik Cherabuddi

  41. Antifungal Potential of Host Defense Peptide Mimetics in a Mouse Model of Disseminated Candidiasis

    Article • Journal of Fungi, February 2018, MDPI AG

    Kartik Cherabuddi

  42. Peripheral T-cell lymphoma mimicking classic Hodgkin’s lymphoma in a patient presenting with fevers of unknown origin

    Article • BMJ Case Reports, February 2018, BMJ

    Kartik Cherabuddi

  43. Ampicillin for the treatment of complicated urinary tract infections caused by vancomycin–resistant Enterococcus spp (VRE): a single-center university hospital experience

    Article • International Journal of Antimicrobial Agents, January 2018, Elsevier

    Kartik Cherabuddi

  44. Pertuzumab and trastuzumab infusion related cytokine release syndrome in a chemotherapy naive patient with metastatic breast cancer

    Article • The Breast Journal, October 2017, Wiley

    Adonice Khoury , Kartik Cherabuddi

  45. Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanism

    Article • Scientific Reports, June 2017, Springer Science + Business Media

    Kartik Cherabuddi

  46. Successful Treatment of Clostridium difficile Bacteremia with Aortic Mycotic Aneurysm in a Patient with Prior Endovascular Aortic Aneurysm Repair

    Article • Case Reports in Infectious Diseases, January 2017, Hindawi Publishing Corporation

    Kartik Cherabuddi

  47. Impact of an Extended Infusion Β-lactam Strategy on Outcomes in Critically Ill Patients with Pseudomonas Infections

    Article • Open Forum Infectious Diseases, January 2017, Oxford University Press (OUP)

    Kartik Cherabuddi

  48. Implementation of a Β-Lactam Therapeutic Drug Monitoring Program

    Article • Open Forum Infectious Diseases, January 2017, Oxford University Press (OUP)

    Kartik Cherabuddi

  49. Reduced Mortality with Early Infectious Disease Consultation in Patients with AmpC Gram-negative Bacteremia

    Article • Open Forum Infectious Diseases, January 2017, Oxford University Press (OUP)

    Kartik Cherabuddi

  50. Refractory acute respiratory failure due to Pneumocystis jiroveci (PCP) and Cytomegalovirus (CMV) pneumonitis: A case report and review of literature

    Article • IDCases, January 2017, Elsevier

    Kartik Cherabuddi

  51. Zika and Chikungunya virus co-infection in a traveller returning from Colombia, 2016: virus isolation and genetic analysis

    Article • JMM Case Reports, November 2016, Society for General Microbiology

    Kartik Cherabuddi

  52. Coinfection With Zika and Dengue-2 Viruses in a Traveler Returning From Haiti, 2016: Clinical Presentation and Genetic Analysis

    Article • Clinical Infectious Diseases, September 2016, Oxford University Press (OUP)

    Kartik Cherabuddi

  53. Case of eastern equine encephalitis presenting in winter

    Article • BMJ Case Reports, May 2016, BMJ

    Kartik Cherabuddi

  54. A decade of antimicrobial stewardship at the University of Florida - Challenges, strategies and outcomes

    Article • International Journal of Infectious Diseases, April 2016, Elsevier

    Kartik Cherabuddi

  55. Clinical Utility of Cefepime for the Management of Bacteremia Secondary to AmpC-Producing Organisms

    Article • Open Forum Infectious Diseases, January 2016, Oxford University Press (OUP)

    Kartik Cherabuddi

  56. Applying Athletic Principles to Medical Rounds to Improve Teaching and Patient Care

    Article • Academic Medicine, July 2014, Wolters Kluwer Health

    Kartik Cherabuddi

  57. Transfer from High-Acuity Long-Term Care Facilities Is Associated with Carriage of Klebsiella pneumoniae Carbapenemase–Producing Enterobacteriaceae: A Multihospital Study

    Article • Infection Control, December 2012, Cambridge University Press

    Kartik Cherabuddi